Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT04410302
Official study title

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Study summary

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedBiospecimen Collection

The study team can explain what participation involves.

Who it may be forBladder Carcinoma · Gastric Carcinoma

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 20, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Observational

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of California, Davis

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of California, Davis
Interventions being studied
Procedure: Biospecimen Collection
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
  • Signed informed consent that will be put on file
Reasons someone may not be able to joinExclusion criteria
  • No informed consent obtained
  • Specimen unacceptable/degraded/etc.
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners
  • Adults unable to consent

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • UC Irvine Health/Chao Family Comprehensive Cancer CenterOrange, California
  • University of California Davis Comprehensive Cancer CenterSacramento, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 20, 2026. Always confirm current availability with the study team.

View original record ↗